Moses Victor Javier Aguilar, Chief Research, Development & Innovation Officer at Procter & Gamble Co (NYSE:PG), filed a Form 4 on September 17, 2026, reporting the acquisition of stock options on September 15, 2026.
Key Highlights
- Option grant: Aguilar acquired 3,519 stock options (right to buy) in Common Stock on September 15, 2026, at an exercise price of $146.67.
- Expiration date: The options are exercisable from September 14, 2029, through September 15, 2036, according to the filing.
- Price of derivative security: The filing reports the price of the derivative security as $0.
- Direct holdings: Following the transaction, Aguilar directly beneficially owns 49,511.0935 shares of Common Stock.
- Indirect holdings: The filing also reports 7,476.1294 shares held indirectly by a Retirement Plan Trustee and 428.6033 shares held indirectly through an International Stock Ownership Plan (Mexico) Trustee.
- Derivative position: Aguilar holds 3,519 derivative securities (stock options) beneficially owned following the reported transaction, held directly.
Aguilar's Option Grant and Beneficial Ownership at Procter & Gamble
According to the Form 4 filed with the SEC on September 17, 2026, Moses Victor Javier Aguilar, identified as Chief Research, Development & Innovation Officer of Procter & Gamble Co (NYSE:PG), reported a single derivative securities transaction dated September 15, 2026. The transaction code is listed as "A," indicating an acquisition. The filing was signed by Wednesday Shipp as attorney-in-fact for Mr. Aguilar Moses.
The filing discloses that Aguilar acquired 3,519 stock options (right to buy Common Stock) at a conversion or exercise price of $146.67 per share. The options become exercisable on September 14, 2029, and expire on September 15, 2036. The price of the derivative security at acquisition is reported as $0. No non-derivative securities transactions were recorded in Table I; only post-transaction beneficial ownership figures are listed there.
In Table I, the filing reports Aguilar's total direct beneficial ownership of Common Stock at 49,511.0935 shares. In addition, 7,476.1294 shares are held indirectly through a Retirement Plan Trustee, and 428.6033 shares are held indirectly through an International Stock Ownership Plan (Mexico) Trustee. The filing was made by one reporting person and indicates no amendment to a prior filing.
What Was Disclosed
The Form 4 discloses the acquisition of 3,519 stock options by Procter & Gamble's Chief R&D Officer on September 15, 2026, at an exercise price of $146.67, along with the reporting person's total direct and indirect beneficial ownership of Common Stock.



Please wait processing your request...